Karen Akinsanya - 30 Mar 2022 Form 3 Insider Report for Nautilus Biotechnology, Inc. (NAUT)

Role
Director
Signature
/s/ Matthew B. Murphy, as Attorney-in-Fact
Issuer symbol
NAUT
Transactions as of
30 Mar 2022
Net transactions value
$0
Form type
3
Filing time
31 Mar 2022, 18:13:01 UTC
Previous filing
09 Feb 2022
Next filing
16 Jun 2022

No securities are beneficially owned.

Remarks:

No Securities beneficially held